Serum tumor markers of head and neck cancer: Current status
- 1 January 1990
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 12 (1) , 50-59
- https://doi.org/10.1002/hed.2880120107
Abstract
The serum level of a variety of substances shows significant changes in head and neck cancer patients. Such substances are collectively called biochemical tumor markers. To date, most markers lack a high degree of specificity and sensitivity. However, serial measurement of markers showing elevated pretreatment levels may help in monitoring response to therapy. Other potential uses of tumor markers include earlier detection of recurrence and/or metastasis, and possible prediction of prognosis. Measurement of more than one marker seems to enhance the diagnostic accuracy of the test. Some markers show significant correlations with various immune parameters in head and neck cancer patients and may have a possible role in potentiating the immunodepressed status of such patients. A review of currently reported tumor markers in head and neck cancer showing their nature, sources, uses, and limitations is presented.Keywords
This publication has 58 references indexed in Scilit:
- SCC‐RIA in the diagnosis of squamous cell carcinoma of the head and neckThe Laryngoscope, 1989
- Immunohistochemical demonstration of carcinoembryonic antigen (CEA) on tissue sections from squamous cell head and neck cancer and plasma CEA levels of the patientsInternational Journal of Oral & Maxillofacial Surgery, 1986
- Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial Determinations and Tissue LocalizationCancer, 1985
- Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancerCancer, 1982
- Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinomaJournal of Clinical Immunology, 1982
- Carcinoembryonic antigen. A useful monitor of therapy of small cell lung cancerJAMA, 1981
- The reversibility of cancer: The relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1Medical Hypotheses, 1980
- Tumor antigen of human cervical squamous cell carcinoma.Correlation of circulating levels with disease progressCancer, 1979
- Quantitation of specific serum glycoproteins in malignancyClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- The value of serum phosphohexose isomerase as an index of metastatic breast carcinoma activityCancer, 1963